Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapyJ. Miao, Chuanwei Zhao, Yixuan Cao et al.|Annals of Oncology|2019Cited by 0